Clinicopathological and prognostic value of LINC01296 in cancers: a meta-analysis

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
   PubMed Web of Science ®Google Scholar
• Weidle UH, Birzele F, Kollmorgen G, et al. Long Non-coding RNAs and their role in metastasis. Cancer Genomics Proteomics. 2017;14:143–160.
   PubMed Web of Science ®Google Scholar
• Yarmishyn AA, Kurochkin IV. Long noncoding RNAs: a potential novel class of cancer biomarkers. Front Genet. 2015;6:145–145.
   PubMed Web of Science ®Google Scholar
• Jiang M, Xiao Y, Liu D, et al. Overexpression of long noncoding RNA LINC01296 indicates an unfavourable prognosis and promotes tumourigenesis in breast cancer. Gene. 2018;675:217–224.
   PubMed Web of Science ®Google Scholar
• Liu B, Pan S, Xiao Y, et al. LINC01296/miR-26a/GALNT3 axis contributes to colorectal cancer progression by regulating O-glycosylated MUC1 via PI3K/AKT pathway. J Exp Clin Cancer Res.. 2018;37:316.
   PubMed Web of Science ®Google Scholar
• Abdeahad H, Avan A, Pashirzad M, et al. The prognostic potential of long noncoding RNA HOTAIR expression in human digestive system carcinomas: a meta-analysis. J Cell Physiol. 2019;234:10926–10933.
   PubMed Web of Science ®Google Scholar
• Xiao M, Feng Y, Liu C, et al. Prognostic values of long noncoding RNA PVT1 in various carcinomas: an updated systematic review and meta-analysis. Cell Prolif. 2018;51:e12519.
   PubMed Web of Science ®Google Scholar
• Wu Y, Ding M, Wei S, et al. The prognostic value of long noncoding RNA ZEB1-AS1 on clinical outcomes in human cancer. J Cancer. 2018;9:3690–3698.
   PubMed Web of Science ®Google Scholar
• Zhao W, Wang Z, Fang X, et al. Long noncoding RNA Breast cancer antiestrogen resistance 4 is associated with cancer progression and its significant prognostic value. J Cell Physiol. 2018;234:12956–12963.
   PubMed Web of Science ®Google Scholar
• Cai J, Zuo X, Chen Z, et al. Prognostic value and clinical significance of long noncoding RNA CASC2 in human malignancies: a meta-analysis. CMAR. 2018;10:1403–1412.
   Web of Science ®Google Scholar
• Seitz AK, Christensen LL, Christensen E, et al. Profiling of long non-coding RNAs identifies LINC00958 and LINC01296 as candidate oncogenes in bladder cancer. Sci Rep. 2017;7:395.
   PubMed Web of Science ®Google Scholar
• Wang L, Meng D, Wang Y, et al. Long non-coding RNA LINC01296 promotes esophageal squamous cell carcinoma cell proliferation and invasion by epigenetic suppression of KLF2. Am J Cancer Res. 2018;8:2020–2029.
   PubMed Web of Science ®Google Scholar
• Qin QH, Yin ZQ, Li Y, et al. Long intergenic noncoding RNA 01296 aggravates gastric cancer cells progress through miR-122/MMP-9. Biomed Pharmacother. 2018;97:450–457.
   PubMed Web of Science ®Google Scholar
• Qiu JJ, Yan JB. Long non-coding RNA LINC01296 is a potential prognostic biomarker in patients with colorectal cancer. Tumour Biol. 2015;36:7175–7183.
   PubMedGoogle Scholar
• Xu L, Wei B, Hui H, et al. Positive feedback loop of lncRNA LINC01296/miR-598/Twist1 promotes non-small cell lung cancer tumourigenesis. J Cell Physiol. 2019;234:4563–4571.
   PubMed Web of Science ®Google Scholar
• Wang X, Wang L, Gong Y, et al. Long noncoding RNA LINC01296 promotes cancer-cell proliferation and metastasis in urothelial carcinoma of the bladder. Onco Targets Ther. 2019;12:75–85.
   PubMed Web of Science ®Google Scholar
• Wu J, Cheng G, Zhang C, et al. Long noncoding RNA LINC01296 is associated with poor prognosis in prostate cancer and promotes cancer-cell proliferation and metastasis. OTT. 2017;10:1843–1852.
   Web of Science ®Google Scholar
• Tierney JF, Stewart LA, Ghersi D, et al. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16.
   PubMed Web of Science ®Google Scholar
• Liang J, Wei X, Liu Z, et al. Long noncoding RNA CYTOR in cancer: a TCGA data review. Clin Chim Acta. 2018;483:227–233.
   PubMed Web of Science ®Google Scholar
• Yuan Q, Zhang Y, Feng L, et al. Upregulated long noncoding RNA LINC01296 indicates a dismal prognosis for pancreatic ductal adenocarcinoma and promotes cell metastatic properties by affecting. J Cell Biochem. 2019;120:552–561.
   PubMed Web of Science ®Google Scholar
• Zhang D, Li H, Xie J, et al. Long noncoding RNA LINC01296 promotes tumour growth and progression by sponging miR-5095 in human cholangiocarcinoma. Int J Oncol. 2018;52:1777–1786.
   PubMed Web of Science ®Google Scholar
• Wang B, Liang T, Li J. Long noncoding RNA LINC01296 is associated with poor prognosis in ESCC and promotes ESCC cell proliferation, migration and invasion. Eur Rev Med Pharmacol Sci. 2018;22:4524–4531.
   PubMed Web of Science ®Google Scholar
• Shen X, Bai Y, Luo B, et al. Upregulation of lncRNA BANCR associated with the lymph node metastasis and poor prognosis in colorectal cancer. Biol Res. 2017;50:32.
   PubMed Web of Science ®Google Scholar
• Gao C, Li H, Zhuang J, et al. The construction and analysis of ceRNA networks in invasive breast cancer: a study based on The Cancer Genome Atlas. CMAR. 2018;11:1–11.
   Web of Science ®Google Scholar
• Wang L, Chunyan Q, Zhou Y, et al. BCAR4 increase cisplatin resistance and predicted poor survival in gastric cancer patients. Eur Rev Med Pharmacol Sci. 2017;21:4064–4070.
   PubMed Web of Science ®Google Scholar
• Feng L, Houck JR, Lohavanichbutr P, et al. Transcriptome analysis reveals differentially expressed lncRNAs between oral squamous cell carcinoma and healthy oral mucosa. Oncotarget. 2017;8:31521–31531.
   PubMedGoogle Scholar
• Yu X, Pang L, Yang T, et al. lncRNA LINC01296 regulates the proliferation, metastasis and cell cycle of osteosarcoma through cyclin D1. Oncol Rep. 2018;40:2507–2514.
   PubMed Web of Science ®Google Scholar